These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 30293912)
1. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases]. Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912 [TBL] [Abstract][Full Text] [Related]
2. How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab. Mlika M; Lamzibri O; Bacha S; Laabidi S; Haddouchi C; Mezni FE J Immunoassay Immunochem; 2018; 39(3):263-273. PubMed ID: 29757709 [TBL] [Abstract][Full Text] [Related]
3. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009. Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956 [TBL] [Abstract][Full Text] [Related]
4. Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea. Kim YK; Kim JS; Lee KW; Yi CA; Goo JM; Jung SH Korean J Radiol; 2016; 17(4):545-53. PubMed ID: 27390546 [TBL] [Abstract][Full Text] [Related]
5. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016). Barbieri PG; Mirabelli D; Magnani C; Brollo A Tumori; 2019 Aug; 105(4):304-311. PubMed ID: 29714657 [TBL] [Abstract][Full Text] [Related]
6. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years. Lin RT; Chang YY; Wang JD; Lee LJ J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200 [TBL] [Abstract][Full Text] [Related]
7. Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population. Gopar-Nieto R; Aguilar-Madrid G; Sotelo-Martínez L; Juárez-Pérez CA; Kelly-García J; Argote-Greene L; Ochoa-Vázquez MD; García-Bazán EM; Ramírez-Pérez J; Haro-García L; Jiménez-Ramírez C; Cabello-López A Arch Med Res; 2015 Feb; 46(2):107-11. PubMed ID: 25707292 [TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis. Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010 [TBL] [Abstract][Full Text] [Related]
9. Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma. Hashimoto M; Sato A; Kuroda A; Nakamura A; Nakamichi T; Kondo N; Yuki M; Nabeshima K; Tsujimura T; Hasegawa S Gen Thorac Cardiovasc Surg; 2020 Aug; 68(8):820-827. PubMed ID: 31981139 [TBL] [Abstract][Full Text] [Related]
10. Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time. Shepherd KE; Oliver LC; Kazemi H Am J Ind Med; 1989; 16(4):373-83. PubMed ID: 2610210 [TBL] [Abstract][Full Text] [Related]
12. [Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg]. Ried M; Speth U; Potzger T; Neu R; Diez C; Klinkhammer-Schalke M; Hofmann HS Chirurg; 2013 Nov; 84(11):987-93. PubMed ID: 23743993 [TBL] [Abstract][Full Text] [Related]
13. Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center. Otoshi T; Kataoka Y; Ikegaki S; Saito E; Matsumoto H; Kaku S; Shimada M; Hirabayashi M PLoS One; 2017; 12(10):e0185850. PubMed ID: 28968445 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma]. Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma. Fortin M; Cabon E; Berbis J; Laroumagne S; Guinde J; Elharrar X; Dutau H; Astoul P Respiration; 2020; 99(1):28-34. PubMed ID: 31655816 [TBL] [Abstract][Full Text] [Related]
17. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009. Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709 [TBL] [Abstract][Full Text] [Related]
18. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects. Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567 [TBL] [Abstract][Full Text] [Related]
19. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904 [TBL] [Abstract][Full Text] [Related]
20. The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma. Ghigna MR; Crutu A; Florea V; Soummer-Feulliet S; Baldeyrou P Cytopathology; 2016 Aug; 27(4):284-8. PubMed ID: 26315262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]